Isoniazid-Associated Hepatitis in 114 Patients
Tóm tắt
Từ khóa
Tài liệu tham khảo
Bernstein, 1952, The chemotherapy of experimental tuberculosis. V. Isonicotinic acid hydrazide (Nydrazid) and related compounds, Am Rev Tuberc Pulm Dis, 65, 357
Steenken, 1952, Antituberculous properties of hydrazines of isonicotinic acid (Rimifon, Marsilid), Am Rev Tuber Pulm Dis, 65
Weinstein, 1970, Drugs used in the chemotherapy of leprosy and tuberculosis, chap 61, 1311
Comstock, 1972, Preventive treatment of untreated nonactive tuberculosis in an Eskimo population, Arch Environ Health, 25, 333, 10.1080/00039896.1972.10666182
Horwitz, 1966, Epidemiological basis of tuberculosis eradication. 4. The isoniazid trial in Greenland, Bull WHO, 35, 509
Ferebee, 1962, Tuberculosis morbidity in a controlled trial of the prophylactic use of isoniazid among household contacts, Am Rev Resp Dis, 85, 490
American Thoracic Society, 1967, Chemoprophylaxis for the prevention of tuberculosis; a statement by an ad hoc committee, Am Rev Resp Dis, 96, 558
Devadatta, 1960, Peripheral neuritis due to isoniazid, Bull WHO, 23, 587
Randolph, 1953, Toxic hepatitis with jaundice occurring in a patient treated with isoniazid, JAMA, 152, 38, 10.1001/jama.1953.63690010014007i
Haber, 1959, Icterus and febrile reactions in response to isonicotinic acid hydrazine, Ν Engl J Med, 260, 417, 10.1056/NEJM195902262600904
Merritt, 1959, Toxic hepatic necrosis (hepatitis) due to isoniazid: report of a case with cirrhosis and death due to hemorrhage from esophageal varrices, Ann Intern Med, 50, 804, 10.7326/0003-4819-50-3-804
Gillis, 1960, Unusual reactions to antituberculosis chemotherapy, Med J Aust, 2, 99, 10.5694/j.1326-5377.1960.tb87016.x
Cohen, 1961, Fatal hepatic necrosis secondary to isoniazid therapy, JAMA, 176, 877, 10.1001/jama.1961.63040230013013b
Reynolds, 1962, Isoniazid jaundice and its relationship to iproniazid jaundice, Tubercle (Lond), 43, 375, 10.1016/S0041-3879(62)80006-3
Case records of the Massachusetts General Hospital, 1962, Ν Engl J Med, 267, 350, 10.1056/NEJM196208162670710
O'Sullivan, 1966, Isoniazid jaundice during the treatment of genitourinary tuberculosis, Tubercle (Lond), 47, 375
Cohen, 1967, Hepatitis por isoniazida, Prensa Med Argent, 54, 70
Lederman, 1968, Exchange transfusion as treatment of acute hepatic failure due to antituberculous drugs, Ann Intern Med, 68, 830, 10.7326/0003-4819-68-4-830
Assem, 1969, Liver damage and isoniazid allergy, Clin Exp Immunol, 5, 439
Martin, 1970, ArthaudJB: Hepatitis after isoniazid administration, Ν Engl J Med, 282, 433, 10.1056/NEJM197002192820808
Grossman, 1970, Jaundice and death from isoniazid, J Tenn Med Assoc, 63, 23
Rester, 1971, Isoniazid hepatotoxicity fact or fantasy, JAMA, 217, 699, 10.1001/jama.1971.03190050155026
Garibaldi, 1972, Isoniazid-associated hepatitis: report of an outbreak, Am Rev Resp Dis, 106, 357, 10.1164/arrd.1972.106.3.357
Moss, 1972, Isoniazid-associated hepatitis. A study of five cases, Am Rev Resp Dis, 106, 849, 10.1164/arrd.1972.106.6.849
Perera, 1969, Hepatocellular damage due to INH, 12
Isoniazid and liver disease, 1971, Report of the ad hoc-committee on isoniazid and liver disease, Center for Disease Control, Am Rev Resp Dis, 104, 454, 10.1164/arrd.1971.104.3.454
Scharer, 1969, Serum transaminase elevations and other hepatic abnormalities in patients receiving isoniazid, Ann Intern Med, 71, 1113, 10.7326/0003-4819-71-6-1113
Bailey, 1973, Disturbed hepatic function during isoniazid chemoprophylaxis, Am Rev Resp Dis, 107, 523, 10.1164/arrd.1973.107.4.523
Mitchell, 1975, Acetylation rates and monthly liver function tests during one year of isoniazid preventive therapy, Chest, 68, 181, 10.1378/chest.68.2.181
Zimmerman, 1972, Drug-Induced Hepatic Injury. Reprinted from Hypersensitivity to Drugs I.E.P.T
Rosen, 1970, Computer analysis of liver function tests and their interrelationships in 347 cases of viral hepatitis, Israel J Med Sci, 6, 67
Prince, 1970, Immunological distinction between infectious and serum hepatitis, Ν Engl J Med, 282, 987, 10.1056/NEJM197004302821801
1974, Morbidity and Mortality, 23, 97
1971, Annual Supplement, summary, vol. 20, 1
Harinasuta, 1971, Alcoholic steatonecrosis. 1. Relationship between severity of hepatic disease and presence of Mallory bodies in the liver, Gastroenterology, 60, 1036, 10.1016/S0016-5085(71)80031-8
Stead, 1973, Isoniazid hepatitis: backlash of progress, Ann Intern Med, 79, 125, 10.7326/0003-4819-79-1-125
Klatskin, 1968, Toxic and drug-induced hepatitis, 498
Adriany, 1960, Toxicity to para-amino salicylic acid and isoniazid, Dis Chest, 38, 107, 10.1378/chest.38.1.107
Alarcon-Segovia, 1971, Isoniazid acetylation rate and development of antinuclear antibodies upon isoniazid treatment, Arthritis Rheum, 14, 748, 10.1002/art.1780140610
Mathews, 1971, Experience with lymphocyte transformation tests in the evaluation of allergy to aminosalicylic acid, isoniazid, and streptomycin (abstr), J Allergy, 47
Dove, 1972, Failure to demonstrate transformation of lymphocytes of patients with isoniazid associated hepatitis, Am Rev Resp Dis, 106, 485, 10.1164/arrd.1972.106.3.485
Mitchell, 1975, Metabolic activation of drugs to toxic substances, Gastroenterology, 68, 392, 10.1016/S0016-5085(75)80025-4
Rosenblum, 1960, Hepatocellular jaundice as a complication of iproniazid therapy, Arch Intern Med, 105, 583, 10.1001/archinte.1960.00270160081010
Kalow, 1962
A cooperative USPHS study. Isoniazid-related hepatitis: a USPHS surveillance study (in preparation)
Mitchell, 1975, Increased incidence of isoniazid hepatitis in rapid acetylators and possible relation to hydrazine metabolites, Clin Pharmacol Ther, 18, 70, 10.1002/cpt197518170
Rao, 1970, Sulphadimidine acetylation test for classification of patients as slow or rapid inactivators of isoniazid, Br Med J, 3, 495, 10.1136/bmj.3.5721.495
Peters, 1965, Studies on the metabolic basis of the genetically determined capacities for isoniazid inactivation in man, J Pharmacol Exp Ther, 150, 298
Snodgrass, 1974, Possible mechanism of isoniazid-related hepatic injury (abstr), Clin Res, 22, 323A
Nelson, 1975, Metabolic activation of hydrazines to reactive intermediates: mechanistic implications for isoniazid and iproniazid hepatitis (abstr), Fed Proc, 34, 784